Abstract
Purpose
Young adult anxiety/depression (mental health) symptoms have increased from prior to the COVID-19 pandemic. This study assessed young adult (aged 18–25 years) anxiety/depressive symptoms, mental health care utilization (prescription drug use, counseling, and/or either), and unmet counseling/therapy needs utilizing the national Household Pulse Survey data from June to July 2021.
Methods
Young adult (n = 2,809) rates and subgroup differences in mental health symptoms (Generalized Anxiety Disorder-2 and/or Patient Health Questionnaire-2) were assessed, as were mental health care utilization and unmet counseling/therapy needs.
Results
In total, 48% of young adults had mental health symptoms. Among those, 39% received treatment and 36% reported unmet mental health counseling/therapy needs.
Discussion
These findings highlight young adults' ongoing mental health needs and low services receipt. Interventions and further research to reduce barriers to seeking and utilizing mental health care and to increase the capacity of providers to deliver culturally appropriate mental health care are needed.
Keywords: Young adults, Mental health, Behavioral health, Unmet need, COVID-19, Healthcare, Utilization, Anxiety, Depression
Implications and Contribution.
In this national young adult sample, 48% reported anxiety and/or depression symptoms indicating need for further screening or treatment. Among those with symptoms, about a third received care and roughly a third expressed unmet counseling/therapy need. Findings indicate sustained elevation of symptoms and low care utilization during the COVID-19 pandemic.
Young adult anxiety and depression are widespread. These conditions increased among adults during the pre-COVID years (from the 2000s to 2017–2018): young adult rates were the highest of any adult age group and their rates increased more than older adults [1,2]. In 2019, 20% of young adults had anxiety symptoms and 21% had depression symptoms [3]. The immediate and long-term implications of untreated mental health conditions on health and well-being are well documented [[4], [5], [6]].
Overall adult mental health symptoms ([MHS]: anxiety and/or depression) increased from pre-COVID-19 to the COVID-19 time frame (early 2020); pre-to-during COVID-19, younger adults aged 18–39 years experienced greater increases in high levels of anxiety symptoms (from 9% to 21%) and moderate to high depression symptoms (9%–39%) than any other adult age group [7,8]. A Center for Disease Control and Prevention study utilizing Household Pulse Survey (HPS) data from June 2020 found that 63% of young adults aged 18–24 years reported MHS, greatly exceeding the full adult sample rate of 31% [9], a finding replicated in a follow-up from September 2020 [10]. Recent research indicates that young adult MHS during the COVID-19 pandemic were associated with job insecurity [11] and loneliness [12].
Young adults also report greater unmet need for mental health services than older adults. In a 2019 subsample comparison of those with any mental illness, 41% of young adults aged 18–25 years reported unmet need for mental health services compared to 26% of all adults [13]. Among all young adults, regardless of symptoms status, unmet counseling need increased from 16% in August 2020 to 23% in January 2021, the highest increase of any adult age group [14].
Using HPS data, the purpose of this study was to investigate the following aims: (1) the current prevalence of young adult anxiety and/or depression symptoms (MHS), and among those with symptoms, rates of (2) mental health service utilization, and (3) unmet mental health counseling/therapy needs.
Methods
Sample
The analytic sample included young adults aged 18–25 years (N = 2,809 of 4,469) who completed the mental health section of the HPS from June 9 to July 5, 2021. The HPS, a national adult online survey conducted by the U.S. Census Bureau in collaboration with the National Center for Health Statistics and other federal agencies, aims to understand the COVID-19 pandemic's impact on U.S. families. The University of California, San Francisco Institutional Review Board approval was granted as exempt status.
Study outcome measures for aims
Aim 1
Establish young adult rates of and subgroup differences in MHS (Generalized Anxiety Disorder-2 [range 0–6] and/or Patient Health Questionnaire-2 [PHQ-2 depression screener]) (range 0–6) [15,16]. Generalized Anxiety Disorder 2 or Patient Health Questionnaire 2 scores of ≥3 indicate that further screening or treatment is advised [15,16].
Aim 2
Among those with MHS, using a single yes/no item, establish rates of last 4 weeks: (a) prescription medication use to help with emotions, concentration, behavior, or mental health (type unspecified), (b) receipt of mental health professional counseling/therapy, and (c) recoded indicator of any treatment accessed: medications use and/or counseling/therapy receipt.
Aim 3
Among those with MHS, using a single yes/no item, establish last 4-week rate of unmet need for mental health counseling/therapy.
Analyses
Analyses estimating outcomes were developed utilizing HPS weights adjusting for nonresponse (personal weight) and the complex survey design (80 replicate weights). Demographic subgroup differences (gender, race/ethnicity, insurance status) in MHS, receipt of services, and unmet need were tested utilizing logistic regression models conducted using SAS 9.4.
Results
Table 1 presents descriptive characteristics of the sample and rates of MHS (anxiety/depression). Forty-eight percent of young adults had MHS. Among subgroups, MHS rates were highest for females (55%), non-Hispanic others (58%), and uninsured young adults (52%), with no significant subgroup differences.
Table 1.
Demographic characteristics weighted % | Mental health symptomsb weighted % | |
---|---|---|
YA analytic samplea (unweighted N = 2,809) | 47.9 | |
Gender | ||
Male | 51.2 | 40.9 |
Female | 48.8 | 55.3 |
Race/ethnicity | ||
NHc-White | 57.9 | 46.5 |
NH-Black | 8.0 | 50.0 |
Hispanic | 23.2 | 50.9 |
NH-Asian | 5.7 | 37.8 |
NH-Other, more than 1 race | 5.2 | 58.3 |
Insurance statusd | ||
Insured | 85.0 | 48.3 |
Uninsured | 15.0 | 51.8 |
Analytic sample included those who completed PHQ2 or/and GAD2 assessment, N = 2,809/4,469 (61.5% of young adult sample).
Mental health symptoms = had PHQ2 and/or GAD2 score ≥3, indicating further screening or treatment advised.
NH = non-Hispanic. YA = young adult.
Missing insurance data (5%) resulted in higher MHS rates for the insurance subgroups than the overall rate for the analytic sample.
Table 2 presents estimates of services utilization and unmet need rates among those with MHS (logistic regression results not tabled). Thirty-one percent had used prescription medications, and rates within subgroups were highest among females (40%), non-Hispanic others (48%), and insured (34%) young adults, with no significant subgroup differences. Twenty-four percent received counseling. Subgroup rates were highest among females (29%), non-Hispanic others (37%), and insured (27%) young adults, with no significant differences. Thirty-nine percent had used medications and/or received counseling, and rates were highest for females (50%), non-Hispanic others (58%), and insured (43%) young adults, with no significant subgroup differences.
Table 2.
Subsample of those positive for mental health symptoms unweighted (N = 1,311) | Receipt of mental health services among those positive for mental health symptoms |
Unmet need for mental health counseling |
||
---|---|---|---|---|
Used prescription meds weighted % | Received counseling weighted % | Received meds or counseling weighted % | Needed counseling but did not get weighted % | |
Analytic subsample | 31.0 | 24.1 | 38.8 | 35.7 |
Gender | ||||
Male | 19.1 | 17.9 | 24.3 | 25.9 |
Female | 40.4 | 28.9 | 50.1 | 43.4 |
Race/ethnicity | ||||
NHa-White | 37.1 | 29.2 | 46.3 | 34.0 |
NH-Black | 6.3 | 9.6 | 11.9 | 22.2 |
Hispanic | 20.3 | 14.2 | 25.9 | 43.9 |
NH-Asian | 34.7 | 22.0 | 35.9 | 26.6 |
NH-Other | 47.7 | 37.2 | 58.4 | 40.4 |
Insurance status | ||||
Insured | 34.1 | 27.4 | 42.6 | 35.0 |
Uninsured | 15.5 | 7.1 | 19.5 | 38.8 |
NH = non-Hispanic.
Among those with MHS, 36% reported unmet counseling need, and females (43%), Hispanic (44%), and uninsured (39%) young adults had the greatest unmet need, with no significant subgroup differences.
Discussion
Nearly half of the young adults exhibited MHS serious enough to warrant further screening or treatment. This finding from early June to early July 2021 shows continued elevation of MHS, extending earlier HPS COVID-19 pandemic findings [9,10]. The lack of significant differences within sex, race/ethnicity, and insurance status may be related to small sample sizes and/or HPS design and sampling factors including the complex survey design adjustments which can result in wide confidence intervals that yield nonsignificant subgroup differences.
Our findings that only about one third of young adults with MHS utilized medications and/or counseling and roughly one third reported unmet care needs support previous research on barriers to care [17] and low mental health care service utilization [18,19].
Given that approximately one third of those with symptoms received care, one might expect that closer to two thirds might report unmet needs. It is possible that those not reporting unmet needs did not recognize or feel that symptoms warranted treatment or feared stigma [17,18].
These findings highlight the importance of improving young adult mental health care through addressing the following: (1) their unique health care seeking considerations including barriers: costs, stigma, confidentiality concerns, and lack of awareness of need for care [17,18]; (2) their health care access and utilization patterns; and (3) the need to increase the size, distribution, and capacity of the mental health care workforce and primary care providers to deliver culturally appropriate mental health care [20].
A strength of this analyses is that it provides recent assessment of MHS and unmet care needs that can be tracked across the pandemic. Limitations include possible bias in results due to missing mental health data for roughly 40% of the sample, and potential noncomparability to longer-standing national survey findings due to significant differences in HPS data collection and editing, time frames of data collected, and data dissemination, all in the effort to provide timely data release for research purposes. The survey did not assess barriers relating to unmet care needs.
The rapid and successful adoption of telehealth care, necessitated by the COVID-19 pandemic, supports further development, optimization, and assessment for delivery of mental health services, both independently and in combination with in-person care [21]. Identification and treatment of young adult anxiety and depression is crucial for supporting healthy development during this life stage that affects present and future well-being across the life course.
Footnotes
Conflicts of interest: The authors have no conflicts of interest to disclose.
Disclaimer: This manuscript has been approved by all authors, is not under review at any other journal, and if accepted, will not be published in any other venue.
Funding Sources
This study was supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) (under #U45MC27709, Adolescent and Young Adult Health Capacity Building Program), with supplemental support from HRSA grants #UA6MC27378 and T71MC0003, and the American Heart Association Career Development Award (CDA34760281). This information or content and conclusions are those of the authors and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS, or the U.S. Government. The sponsors had no role in the preparation or submission of this article.
References
- 1.Goodwin R.D., Weinberger A.H., Kim J.H., et al. Trends in anxiety among adults in the United States, 2008 – 2018: Rapid increases among young adults. J Psychiatr Res. 2020;130:441–446. doi: 10.1016/j.jpsychires.2020.08.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Twenge J.M., Cooper A.B., Joiner T.E., et al. Age, period, and cohort trends in mood disorder indicators and suicide-related outcomes in a nationally representative dataset, 2005 – 2017. J Abnorm Psychol. 2019;128:185–199. doi: 10.1037/abn0000410. [DOI] [PubMed] [Google Scholar]
- 3.Vahratian A., Terlizzi E.P., Villarroel M.A., et al. Mental health in the United States: New estimates from the National Center for Health Statistics. https://www.cdc.gov/nchs/data/events/nhis-mental-health-webinar-2020-508.pdf Available at:
- 4.Heslin K.C., Weiss A.J. Hospital readmissions involving psychiatric disorders, 2012. Healthcare Cost and Utilization Project, Agency for Healthcare Research and Quality. 2015. https://www.hcup-us.ahrq.gov/reports/statbriefs/sb189-Hospital-Readmissions-Psychiatric-Disorders-2012.pdf Available at: [PubMed]
- 5.World Health Organization Mental health: Strengthening our response web site. http://www.who.int/mediacentre/factsheets/fs220/en/ Available at:
- 6.Centers for Disease Control and Prevention Learn about mental health web site. https://www.cdc.gov/mentalhealth/learn/index.htm Available at:
- 7.Daly M., Robinson E. Anxiety reported by US adults in 2019 and during the 2020 COVID-19 pandemic: Population-based evidence from two nationally representative samples. J Affect Disord. 2021;286:296–300. doi: 10.1016/j.jad.2021.02.054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Ettman C.K., Abdalla S.M., Cohen G.H., et al. Prevalence of depression symptoms in US adults before and during the COVID-19 pandemic. JAMA Netw Open. 2020;3 doi: 10.1001/jamanetworkopen.2020.19686. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Czeisler M.E., Lane R.I., Petrosky E., et al. Mental health, substance use, and suicidal ideation during the COVID-19 pandemic – United States, June 24-30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1049–1057. doi: 10.15585/mmwr.mm6932a1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Czeisler M.E., Lane R.I., Wiley J.F., et al. Follow-up survey of US adult reports of mental health, substance use, and suicidal ideation during the COVID-19 pandemic, September 2020. JAMA. 2020;4 doi: 10.1001/jamanetworkopen.2020.37665. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Ganson K.T., Tsai A.C., Weiser S.D., et al. Job insecurity and symptoms of anxiety and depression among U.S. young adults during COVID-19. J Adolesc Health. 2021;68:53–56. doi: 10.1016/j.jadohealth.2020.10.008. [DOI] [PubMed] [Google Scholar]
- 12.Lee C.M., Cadigan J.M., Rhew I.C. Increases in loneliness among young adults during the COVID-19 pandemic and association with increases in mental health problems. J Adolesc Health. 2020;67:714–717. doi: 10.1016/j.jadohealth.2020.08.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2018 and 2019. https://www.samhsa.gov/data/sites/default/files/reports/rpt29394/NSDUHDetailedTabs2019/NSDUHDetTabsSect8pe2019.htm Available at:
- 14.Vahratian A., Blumberg S.J., Terlizzi E.P., Schiller J.S. Symptoms of anxiety or depressive disorder and use of mental health care among adults during the COVID-19 pandemic — United States, August 2020–February 2021. https://www.cdc.gov/mmwr/volumes/70/wr/mm7013e2.htma.network.com/ Available at: [DOI] [PMC free article] [PubMed]
- 15.Staples L.G., Dear B.F., Gandy M., et al. Psychometric properties and clinical utility of brief measures of depression, anxiety, and general distress: The PHQ-2, GAD-2, and K-6. Gen Hosp Psychiatry. 2019;56:13–18. doi: 10.1016/j.genhosppsych.2018.11.003. [DOI] [PubMed] [Google Scholar]
- 16.CDC Centers for Disease Control and Prevention. National Center for Health Statistics Anxiety and depression; household pulse survey web page. https://www.cdc.gov/nchs/covid19/pulse/mental-health.htm Available at:
- 17.Cadigan J.M., Lee C.M., Larimer M.E. Young adult mental health: A prospective examination of service utilization, perceived unmet service needs, attitudes, and barriers to service use. Prev Sci. 2019;20:366–376. doi: 10.1007/s11121-018-0875-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.American Psychiatric Association Stigma, prejudice, and discrimination against people with mental illness website. https://www.psychiatry.org/patients-families/stigma-and-discrimination Available at:
- 19.Adams S.H., Knopf D.K., Park M.J. Prevalence and treatment of mental health and substance use problems in the early emerging adult years in the United States: Findings from the 2010 National Survey on Drug Use and Health. Emerg Adulthood. 2014;2:163–172. [Google Scholar]
- 20.Kaiser Family Foundation mental health care health professional shortage areas (HPSAs) https://www.kff.org/other/state-indicator/mental-health-care-health-professional-shortage-areas-hpsas/?currentTimeframe=0&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D Available at:
- 21.Barney A., Buckelew S., Mesheriakova V., Raymond-Flesch M. The COVID-19 pandemic and rapid implementation of adolescent and young adult telemedicine: Challenges and opportunities for innovation. J Adolesc Health. 2020;67:164–171. doi: 10.1016/j.jadohealth.2020.05.006. [DOI] [PMC free article] [PubMed] [Google Scholar]